- J Todd Weber, on assignment from US Centers for Disease Control and Prevention1,
- Angus Nicoll, coordinator1,
- Carolyn B Bridges, associate director for science2,
- Bruno C Ciancio, senior expert1
- 1Influenza Programme, European Centre for Disease Prevention and Control (ECDC), 171 83 Stockholm, Sweden
- 2Influenza Division, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA
Jefferson and colleagues describe the effectiveness of neuraminidase inhibitors in otherwise healthy adults infected with seasonal flu virus,1 but it is mainly the A/H1N1 flu virus that is currently in circulation.
Given the limited availability of vaccine against 2009 pandemic A/H1N1 flu, antiviral drugs have assumed a prominent role in reducing severe flu …